Utah Medical Products, Inc.
UTMD
$63.12
$0.250.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -7.82% | -1.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.82% | -1.42% | |||
| Cost of Revenue | -10.15% | -3.44% | |||
| Gross Profit | -6.07% | 0.16% | |||
| SG&A Expenses | -8.37% | 22.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.60% | 5.17% | |||
| Operating Income | -6.03% | -13.69% | |||
| Income Before Tax | -6.13% | -13.74% | |||
| Income Tax Expenses | -20.35% | -13.96% | |||
| Earnings from Continuing Operations | -2.47% | -13.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.47% | -13.68% | |||
| EBIT | -6.03% | -13.69% | |||
| EBITDA | -5.06% | -11.04% | |||
| EPS Basic | -2.17% | -12.64% | |||
| Normalized Basic EPS | -5.50% | -9.07% | |||
| EPS Diluted | -2.22% | -12.67% | |||
| Normalized Diluted EPS | -5.50% | -9.07% | |||
| Average Basic Shares Outstanding | -0.31% | -1.19% | |||
| Average Diluted Shares Outstanding | -0.31% | -1.19% | |||
| Dividend Per Share | 1.64% | 0.00% | |||
| Payout Ratio | 0.01% | 0.14% | |||